Compounds useful for treating neurodegenerative disorders

Details for Australian Patent Application No. 2012211417 (hide)

Owner Satori Pharmaceuticals, Inc.

Inventors Findeis, Mark A.; Pal, Kollol; Schroeder, Frank

Agent Davies Collison Cave

Pub. Number AU-A-2012211417

Parent 2006247244

Filing date 8 August 2012

Wipo publication date 30 August 2012

International Classifications

C07J 53/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/58 - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

C07J 71/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

23 August 2012 Complete Application Filed

30 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211417

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211418-A Connector

2012211416-A blower vacuum device